Plain-English translation of NCT07219407 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a long-term study testing , a new medication designed to help control focal seizures in adults whose seizures haven't responded well to other treatments. Researchers want to understand how safe the medication is over time and how well it works for people who have already tolerated it in an earlier trial. The study involves about 30 participants across multiple medical centers.
Many people with focal epilepsy continue to have seizures even after trying several medications. This study exists to see whether this new treatment option can help adults who have had limited success with existing seizure medications.
You likely qualify if…
You likely don't qualify if…
As a participant, you would take the medication as directed while continuing your regular care with the study team. You'll have visits to check on your health, safety, and how well the medication is working, likely including blood tests and heart monitoring. The study is designed to last long-term, allowing researchers to gather information about both the safety and effectiveness of the treatment over an extended period.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States